Thursday 9 th July 2015
|
|
|
- Mary Flowers
- 7 years ago
- Views:
Transcription
1 Thursday 9 th July 2015 Location Registration & Speaker Preview Open West Entrance, Ground Floor, The Sage Roche Sponsored Breakfast Session (Breakfast will be provided) Not included in the main session CME/CPD credit The Barbour Room Avastin (bevacizumab) in advanced Cervical Cancer: What does a surgeon need to know? Dr Amanda Tristram, Consultant Gynaecological Oncologist, finds out from Dr Emma Hudson, Consultant Medical Oncologist, both from South East Wales Gynaecological Oncology Centre, Cardiff, Wales Q&A 09:00 10:00 BGCS Session :30 09: :45-10:00 BGCS Commissioning Subgroup Update Andy Nordin BGCS Guidelines Subgroup Update Desmond Barton BGCS Training Subgroup Update: Training in Gynaecological Oncology Moving Forward Jo Nieto BGCS/BSGOG National Surgical Database Update Raj Naik 10:00 10:10 Welcome: International Benchmarking Ali Kucukmetin, Gateshead, Chair of the Scientific Committee 10: Plenary Session: International Benchmarking & Ovarian Cancer 10:10 10:35 10:35 10:50 10:50 11:10 11:10 11:30 11:30-12:00 Keynote Lecture: International Benchmarking of Gynaecological Cancer Survival - Insights from the CONCORD-2 Study Michel Coleman Symptoms, Surgery or Systemic therapy? Explaining Low Survival in The UK John Butler Impact of the Amount of Residual Disease in Ovarian Cancer During the Last 20 Years Luis Chiva Keynote Lecture- Surgery in Advanced Ovarian Cancer. Where are we going? Christophe Pomel Regional Therapy for Ovarian Cancer: IP and HIPEC William Helm 1
2 Lunch / Exhibition / Poster Viewing Northern Rock Foundation Hall / Level 1 Foyer 12:15 13: :20-13:30 13:30-13:50 AstraZeneca Sponsored Industry Session Not included in the main session CME/CPD credit Shaping the Future Outcomes in Ovarian Cancer Formal Welcome And Introduction Evelyn O Rourke, Professional broadcaster Meet the Expert Professor Richard Edmondson, St Mary s Hospital Meet the expert Dr Rebecca Kristeleit, UCLH Meet the expert Katherine Taylor, Ovarian Cancer Action Panel Discussion All speakers Summary and Conclusions Evelyn O Rourke, Professional broadcaster Awards Ceremony - Lifetime Achievement Award (J M Monaghan) Cancer Services Commissioning and Strategy - The National Perspective Sean Duffy The Barbour Room 13: Plenary Session: Cervical Cancer & Endometrial Cancer 13:50 14:20 14:20 14:40 14:40 14:50 14:50 15: Is Paraaortic Lymphadenectomy Required for Locally Advanced Cervical Cancer? Debate For : Stephen Dobbs Against: Christophe Pomel Uncertainties in the Staging and Treatment of Endometrial Cancer Christhardt Kohler Adjuvant Chemotherapy in Endometrial Cancer Including Uterine Serous Cancers Nick Reed O-1 Reappraisal of the Surgical Management of Isolated Lateral Pelvic Wall Tumour Recurrence Samar Elorbany, Oxford University, UK and Oxford University NHS Trust, UK O-2 Use of SonoVue Microbubbles in Detection of Sentinel Lymph Nodes in Early-stage Vulvar Cancer: Results of a Pilot Study. Nithya Ratnavelu, Northern Gynaecological Oncology Centre, UK O-3 Cervical Cancer Surgery and Fertility-sparing Techniques: A Survey of UK-based Practice. Georgios Theophilou, St James s University Hospital, UK 2
3 15:20 15:50 Tea/Coffee/Exhibition/Poster Viewing Northern Rock Foundation Hall / Level 1 Foyer Plenary Session: Cervical Cancer & Endometrial Cancer 15:50-16:30 16: : : Management of Locally Advanced Cervical Cancer Debate For Surgery: Michael Hockel For Chemoradiotherapy: Alex Taylor For Neoadjuvant Chemotherapy followed by Surgery: Stephano Greggi O-4 Follow-up after Treatment of Cervical Cancer should include Routine Imaging to Identify Early Relapse Marielle Nobbenhuis, The Royal Marsden NHS Foundation Trust, UK O-5 Comparing Hospital and Telephone follow-up for Women Treated for Endometrial Cancer (ENDCAT Trial) Nick Wood, Lancashire Teaching Hospitals NHS Foundation Trust, UK O-6 Fourier Transform Infrared Spectroscopy for the Biomolecular Assessment of Vulval Intraepithelial Neoplasia and Lichen Sclerosus Jonathan Frost, Gloucestershire Hospitals NHS Foundation Trust, UK and University of Exeter, UK 17:00 18:00 Video Session 17:00 17:10 17:10 17:20 17:20 17:30 17:30 17:40 17:40 17:50 17:50 18:00 Electrosurgery in Gynaecological Oncology David Cibula PA Node Dissection Ann Fisher / Ali Kucukmetin / Christophe Pomel Nerve Sparing Uterine Artery Preserving Trachelectomy Ali Kucukmetin Reconstruction of the Urinary Tract for Gynecologic Oncologist Luis Chiva Vulva Field Resection (VFR) and Anatomical Reconstruction Michael Hockel Laparoscopic Diaphragmatic Resection Ali Kucukmetin Late Conference Dinner St James Park 3
4 Friday 10 th July 2015 Location Registration & Speaker Preview Open West Entrance, Ground Floor, The Sage 08:00-08:30 BGCS AGM Plenary Session: Ovarian Cancer & Vulvar Cancer 08:30 08:40 08:40 08:50 08:50 09:00 09:00 09:10 09:10 09:20 09:20 09:30 O-7 Peritonectomy and Resection of Mesentery/Mesocolon during Debulking of Patients with Stage III-IV Ovarian Cancer: A Pilot Study Hooman Soleymani majd, Oxford University Hospitals NHS Trust, Churchill Hospital, UK O-8 Cardiopulmonary Exercise Testing in the Peri-operative Risk Assessment of Women Undergoing Surgery for Advanced Ovarian Cancer Melissa Bradbury, Northern Gynaecological Oncology Centre, UK O-9 Impact of Ultra-radical Surgery in Optimal Management of Patients with Stage IIIC/IV Ovarian Cancer Hilary Turnball, Norfolk & Norwich University Hospital, UK O-10 The Role of Radical Anovulvectomy in the Treatment of Advanced Vulval Carcinoma Rachel O Donnell, Northern Gynaecological Oncology Centre, UK O-11 Ultraradical Surgery for Ovarian Cancer: Time to Chemotherapy and Morbidity Nithya Ratnavelu, Northern Gynaecological Oncology Centre, UK O-12 Post-operative Imaging Versus Surgical Debulking Status as a Predictor of Survival in Ovarian Cancer Mark McComiskey, Christie Hospital, UK 09:30-10:30 Plenary Session Sentinel Node in Gynaecological Malignancies 09:30 09:50 09:50 10:10 10:10 10:30 Sentinel Node in Vulval Cancer Ate van der Zee Sentinel Node in Cervical Cancer David Cibula Sentinel Node in Edometrial Cancer Rene Verheijen 4
5 Tea/Coffee/Exhibition/Poster Viewing Northern Rock Foundation Hall / Level 1 Foyer 11:00 11:30 11:30 12:00 12:00 12:20 12:20 12:40 12:40 13:00 Cost Effectiveness and Standard use of Bevacizumab in 1st Line and Recurrent Ovarian Cancer Bradley Monk Non-Surgical Management of Recurrent Cervical Cancer Bradley Monk Beyond Platinum Resistance in Ovarian Cancer Hani Gabra BRCA Mutations and PARP Inhibitors Update Jonathan Ledermann Surgical and Non-Surgical Management of Low Grade Serous Cancer of the Ovary Charlie Gourley NFGON Parallel Session Introduction by Chair The Challenges of Changing Follow-Up in Gynaecological Cancer s Yvonne Anderson Follow-Up in the Younger Adult-Tailoring it to Their Needs David Short C Tea/Coffee/Exhibition/Poster Viewing A New Era of Support for Women with Endometrial Cancer Emma Azeem How can Service Improvement Tools Help You? Tracy Ward Closing Remarks Lunch/Exhibition/Poster Viewing Northern Rock Foundation Hall / Level 1 Foyer Roche Sponsored Industry Session Not included in the main session CME/CPD credit Optimising aoc outcomes with Avastin (bevacizumab): Why the surgeon is critical Chair: Mr Raj Naik (QE Hospital, Gateshead) Dr. Rebecca Kristeleit (UCLH, London) The oncologist s perspective Prof Christina Fotopoulou (Imperial, London) The surgeon s perspective Group discussion led by Raj Naik, incl Prof Bradley Monk for an international perspective The Barbour Room 5
6 14:20-14:30 14:30-15:10 15:10-15:20 15:20-15:30 Awards Ceremony - Lifetime Achievement Award (CC) Keynote Lecture: Introduction Into Cancer Field Theory And Clinical Translation of the Concept Into Cervical Cancer Surgery (TMMR, LEER) Michael Hockel Intra-Operative Radiotherapy (IORT) Nick Reed Patient Information and Implementations of BRCA Testing Tracie Miles 15:30 17:00 Plenary Session: International Society Parallel Sessions UK Society Parallel Session 15:30-15:40 15:40-15:50 15:50-16:00 O-13 Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer: Support for a Clinical Trial or Routine Care amongst UK Clinicians Dhivya Chandrasekaran, Northampton General Hospital, UK O-14 The Diagnostic Value of Adding HE4 to Ca125 for Symptomatic Women Investigated for Ovarian Cancer in Primary Care: Final Results of a Prospective Pilot Study Christina Founta, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, UK O-15 Retrospective Analysis of Suspicious Pelvic Masses using The Pelvic Mass Index (PMI) Scoring System: The Cardiff Experience to 2014 Florian Drews, University Hospital of Wales,, UK 16:00-16:20 16:20-16:30 16:30-17:00 BGCS Non-Surgical Oncology Subgroup Update Jonathan Ledermann Commissioning Changes: Where we want to be in the Future Rob Gornal Opportunistic Bilateral Salpingectomy at Benign Gynaecological Surgery Ranjit Manchanda Ian Harley 15:30 17:00 Plenary Session: International Society Parallel Sessions Greek Society Parallel Session The Barbour Room Current Trends and Innovative Approaches for Gynecological Cancer Management Chairs : A. Rodolakis & K. Pavlaki Fertility Sparing Surgery for Carcinoma of the Cervix, The Alexandra Hospital 10-year experience Nikolaos Thomakos 6
7 Clinicopathologic Parameters Related to Vulvar Vancer Reccurence and Survival Demetrios Papatheodorou Risk of Malignancy in Solid Uterine Tumors. A Diagnostic, Pathologic and Therapeutic Challenge Kitty Pavlaki Uterine Conservation in Young Women with Endometrial Cancer. The Iaso Hospital 8-year Experience Theodoros Panoskaltsis Conclusions 15:30 17:00 Plenary Session: International Society Parallel Sessions Turkish Society Parallel Session Chairs : S. Ozalp & K. Yuce C Lifetime achievement award for Ali Ayhan Ali Kucukmetin, Faruk Kose Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer A. Ayhan Hepatoduedenal Ligament and Celiac Plexus Exploration and Tumor Resection H. Guner, A. Onan, C. Taskiran Step by step upper quadrant peritonectomy G. Tulunay, N. Boran Peritonectomy K. Yuce, N. Ozgul, C. Salman Rectosigmoid Resection And Anastomosis U. F. Ortac Pelvic Exentration M. Arvas, F. Demirkıran, T. Bese Laparoscopic Pelvic and Paraaortic Lymphadenectomy A. Altintas, M. A. Vardar Lymphadenectomy in Epithelial Ovarian Cancer M. F. Kose, M. M. Naki Robotic Extraperitoneal Paraaortic Lymphadenectomy M. C. Yenen, M. Dede Robotic Radical Trachelectomy I. Dunder, M. Gungor Laparoscopic Sigmoid Interposition A. Karateke Close of Conference 7
How To Compare The Effects Of A Hysterectomy And A Hysterectomy
A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer
INTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of radical laparoscopic hysterectomy for early stage cervical cancer Introduction This overview
Gynaecological Cancers 2015
Gynaecological Cancers 2015 Annex D Epidemiology 1. It is estimated that there will be an increase in the incidence of gynaecological cancers by 2015. For example: a. The incidence of cervical cancer is
Surgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
CADAVERIC DISSECTION COURSE MULTIDISCIPLINARY SURGICAL TECHNIQUES ON GYNECOLOGIC ONCOLOGY
CADAVERIC DISSECTION COURSE MULTIDISCIPLINARY SURGICAL TECHNIQUES ON GYNECOLOGIC ONCOLOGY TREATMENT OF ADVANCED OVARIAN CANCER WITH SPECIAL EMPHASIS ON CYTOREDUCTIVE SURGERY AND HIPEC October 18th-19th,
Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change
FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area
Role of Robotic Surgery in Obese Women with Endometrial Cancer
Role of Robotic Surgery in Obese Women with Endometrial Cancer Anil Tailor Consultant Gynaecological Oncologist Royal Surrey County Hospital Guildford, Surrey, UK St Peters Hospital Chertsey, Surrey, UK
Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone
Overview of Gynaecologic Cancer
Overview of Gynaecologic Cancer Stuart Salfinger Gynaecologic Oncologist St John of God Hospital King Edward Memorial Hospital Cervical Cancer Cervical Cancer Risk HPV Smoking?OCP Cervical Cancer Symptoms
Frequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
The Role of Laparoscopy in Endometrial Cancer
The Role of Laparoscopy in Endometrial Cancer Prof. Dr. Tugan BEŞE İstanbul University, Cerrahpaşa Medical Faculty Gynecologic Oncology Department Surgical staging in Endometrial Cancer Laparoscopic surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER
COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards
Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
Date: 06/06/2014 Our ref: 4496. I write in response to your request for information in relation to treatment for endometrial cancer in NHS Lothian.
Lothian NHS Board Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone 0131 536 9000 Fax 0131 536 9088 www.nhslothian.scot.nhs.uk Date: 06/06/2014 Our ref: 4496 Enquiries to: Bryony Pillath Extension:
2016 Hysterectomy Reimbursement Fact Sheet
2016 Hysterectomy Reimbursement Fact Sheet The information contained in this document is provided for informational purposes only and represents no statement, promise, or guarantee by Ethicon concerning
How To Perform Da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
Common Surgical Procedures Gyn/Oncology
Malignancy Description Codes wrvu Comments Cervical Typical Open Cone biopsy 57520 4.11 Leep conization 57522 3.67 Colposcopy/Leep 57461 3.43 TAH +/- BSO 58150 17.31 Radical hysterectomy +/- BSO (Total,
Corporate Medical Policy
Corporate Medical Policy Proteomics-based Testing Related to Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteomics_based_testing_related_to_ovarian_cancer 7/2010
The ovaries are part of a woman s reproductive system. There are two ovaries, the size and shape of almonds, one on either side of the womb.
Surgery for Suspicious Ovarian Cysts Patient Information sheet The Ovaries The ovaries are part of a woman s reproductive system. There are two ovaries, the size and shape of almonds, one on either side
Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds
Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
Breast cancer research and a changing treatment pathway
Breast cancer research and a changing treatment pathway Stuart McIntosh Clinical Senior Lecturer in Surgical Oncology, QUB Consultant Breast Surgeon, BCH What is the breast surgeon s role in 2016? Surgery
Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S.
Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S. Gynecologic Oncology, Surgery and Endoscopy 4370 Alpine Road Portola Valley, CA 94028-7523 Phone: (650)-851-6669 FAX: (650) 851-9747 Regarding Ovarian Cancer,
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma Focus on stage III and IV melanoma In partnership with the Society of Surgical Oncology (SSO) 12-14 November 2015 ATHENS (GR)
How To Teach A Patient To Live With A Tumour
RECTAL CANCER WHEN TO OPERATE Operative Treatment Strategies... From Minimal to Maximal Champalimaud Foundation Lisbon, Portugal 7 th - 8 th November 2014 Organisation - Champalimaud Foundation Amjad Parvaiz
2014 OB/GYN Surgery Medicare Reimbursement Coding Guide
2014 OB/GYN Surgery Medicare Reimbursement Coding Guide Effective January 1, 2014 Medicare National Average Rates and Allowables (Not Adjusted For Geography) CPT * HCPCS Code 58150 58152 58180 58200 58210
PRIMARY TREATMENT CLINICAL PRESENTATION INITIAL EVALUATION. Conclude procedure with/without lymph node dissection
INITIAL EVALUATION History and Physical CXR Pathology review 1 Labs Consider CA125, and pre-operative imaging of abdomen and pelvis Screen for Lynch Syndrome by family history or molecular testing CLINICAL
How To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
Why would you need a hysterectomy?
Why would you need a hysterectomy? Removal of the uterus is performed to prevent, alleviate, or treat pain, pressure, bleeding, or cancer. Each reason is described in detail in the following pages. Benign
The percentage of women 21-64 years of age who received one or more Pap tests to screen for cervical cancer.
Measure Name: Cervical Cancer Screen Owner: NCQA (CCS) Measure Code: CER Lab Data: Y Rule Description: General Criteria Summary The percentage of women 21-64 years of age who received one or more Pap tests
Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue
page 1 Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue Q: What is breast cancer, and what type do I have? A: Cancer is a disease in which cells become abnormal and form more cells in
Introduction to the Gynaecological Oncology Multi-disciplinary Team (MDT) and the Macmillan Gynaecology Service
Saint Mary s Hospital Introduction to the Gynaecological Oncology Multi-disciplinary Team (MDT) and the Macmillan Gynaecology Service Information for patients What is a Macmillan Gynaecology Nurse Specialist?
NHS STANDARD CONTRACT FOR COMPLEX GYNAECOLOGY- SPECIALIST GYNAECOLOGICAL CANCERS. Complex Gynaecology -Specialist Gynaecological Cancers
E10/S/f NHS STANDARD CONTRACT FOR COMPLEX GYNAECOLOGY- SPECIALIST GYNAECOLOGICAL CANCERS SCHEDULE 2- THE SERVICES A. SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead Provider
Breast Health Program
Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,
GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision
RADIATION THERAPY FOR GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT GYNECOLOGIC CANCERS Gynecologic cancers
Endoscopic Surgical Procedures for Cervical Cancer Treatment: A Literature Review
Endoscopic Surgical Procedures for Cervical Cancer Treatment: A Literature Review Andrea Tinelli, Antonio Perrone Department of Obstetrics and Gynaecology Vito Fazzi Hospital, Lecce, Italy Sarah Gustapane,
Progress and Prospects in Ovarian Cancer Screening and Prevention
Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Carcinosarcoma of the Ovary
Carcinosarcoma of the Ovary A Rare Finding Presented By: Kathryn Kiely Anisa I. Kanbour School of Cytotechnology of the University of Pittsburgh Medical Center Pittsburgh, PA Patient History 55 year old
SCAN Gynaecological Group. Clinical Management Protocols: Cancer of the Cervix. www.scan.scot.nhs.uk
SE Scotland Cancer Network SCAN Gynaecological Group Clinical Management Protocols: Cancer of the Cervix www.scan.scot.nhs.uk Table of contents 3 Introduction 4 Diagnosis 5-6 Staging and spread of disease
In 2010, gynecologic malignancies
Reviews ONCOLOGY Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations Ritu Salani, MD, MBA; Floor J. Backes,
Ovarian Cancer Genetic Testing: Why, When, How?
Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine
Gynäkologische Onkologie-Klinische Studien
Gynäkologische Onkologie-Klinische Studien Breast cancer A randomized, phase 2 trial of AEZS-108 in chemotherapy refractory triple negative (ER/PR/HER2-negative) LHRH-R positive metastatic breast cancer
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28)
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28) Tracking Information Publication Number Manual Section Number 100-3 190.28 Manual Section Title Tumor Antigen by
Radical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy Versus Laparotomy
SCIENTIFIC PAPER Radical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy Versus Laparotomy Sarah E. Taylor, MD, William C. McBee Jr., MD, Scott D. Richard, MD, Robert P. Edwards, MD ABSTRACT
The main surgical options for treating early stage cervical cancer are:
INFORMATION LEAFLET ON TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY (TLRH) FOR EARLY STAGE CERVICAL CANCER (TREATING EARLY STAGE CERVICAL CANCER BY RADICAL HYSTERECTOMY THROUGH KEYHOLE SURGERY) Aim of the leaflet
A Checklist for Patients with Breast Cancer
A Checklist for Patients with Breast Cancer Questions to Ask the Doctor 1 and Quick Help Resources 1 Adapted from: American Cancer Society. Detailed Guide: Breast Cancer - What Should You Ask Your Doctor
Building Awareness of Cervical Cancer
Building Awareness of Cervical Cancer Guest Expert: Peter, MD John Slade Ely Professor of Obstetrics, Gynecology & Reproductive Sciences www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center
RESEARCH ARTICLE. Abstract. Introduction. Materials and Methods
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.13.5483 Perioperative and Oncologic Outcomes with Laparotomy, and Laparoscopic, and Robotic Surgery for Endometrial Cancer RESEARCH ARTICLE Comparison of Perioperative
Probe: Could you tell me about when?
PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:
Ovarian cancer. A guide for journalists on ovarian cancer and its treatment
Ovarian cancer A guide for journalists on ovarian cancer and its treatment Contents Contents 2 3 Section 1: Ovarian Cancer 4 i. Types of ovarian cancer 4 ii. Causes and risk factors 5 iii. Symptoms and
Cancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
A Practical Guide to Advances in Staging and Treatment of NSCLC
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
How to treat early gastric cancer. Surgery
How to treat early gastric cancer Surgery Mark I. van Berge Henegouwen Department of Surgery, AMC, Amsterdam Director upper GI surgical unit Academic Medical Center Upper GI surgery at AMC 100 oesophagectomies
Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer
Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer Camran Nezhat,, MD, FACOG, FACS Stanford University Medical Center Center for Special Minimally Invasive
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience
Original Article Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience Claudia Arispe, Ana Isabel Pomares, Javier De Santiago, Ignacio Zapardiel
Surgical guidelines for the management of breast cancer
Available online at www.sciencedirect.com EJSO xx (2009) S1eS22 www.ejso.com Guidelines Surgical guidelines for the management of breast cancer Contents Association of Breast Surgery at BASO 2009 Introduction...
3 д д д д д длд д дбднд д д д д д д д д д д»д д д д д д д
да' дгдадедцд д дедфдд дфдаде дбд дгдадедфд»дфд»дбдедфдд дфдфдедгдедфдд д дадгдцд дед д дддгдед»д дадедддгдидг дцдедцд дед дгд ддд : дфдадедддбддд ддд да. дадгд д дадфдфддд д дгдддгда дбд дгдадедфд»дфд»дбдедфддд
Treatment options for recurrent ovarian cancer
Treatment options for recurrent ovarian cancer There are a number of treatment options for women with recurrent ovarian cancer. Chemotherapy is the treatment most commonly offered and on occasion, surgery
Chemotherapy in Ovarian Cancer. Dr R Jones Consultant Medical Oncologist South Wales Gynaecological Oncology Group
Chemotherapy in Ovarian Cancer Dr R Jones Consultant Medical Oncologist South Wales Gynaecological Oncology Group Adjuvant chemotherapy for early stage EOC Fewer than 30% women present with FIGO stage
Hereditary Breast and Ovarian Cancer (HBOC)
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Hereditary Breast and Ovarian Cancer (HBOC) Information for women with an increased lifetime risk of breast and ovarian cancer What
Guide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
PRESENTATION OF NOVEL GYNECOLOGIC ONCOLOGY PROCEDURES M.D. ANDERSON CANCER CENTER, UNIVERSITY OF TEXAS November 15, 2006
PRESENTATION OF NOVEL GYNECOLOGIC ONCOLOGY PROCEDURES M.D. ANDERSON CANCER CENTER, UNIVERSITY OF TEXAS November 15, 2006 00:00:11 ANNOUNCER: This program is made possible through an educational grant from
Clinical Practice Assessment Robotic surgery
Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through
Breast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org
Breast Cancer s Link to Ovarian Cancer: It s in Your Genes foundationforwomenscancer.org There are now more than 2.6 million women in America who have been diagnosed with breast cancer. A very small fraction
Cancer of the Cervix
Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,
Friday, June 14, 2013 Evening Reception 7-9pm Saturday, June 15, 2013 7am - 5pm at Jump Trading Simulation & Education Center Peoria, Illinois
Robotics 2013 Symposium Friday, June 14, 2013 Evening Reception 7-9pm Saturday, June 15, 2013 7am - 5pm at Jump Trading Simulation & Education Center Peoria, Illinois Jointly sponsored by Background The
Gynecologic Cancer in Women with Lynch Syndrome
Gynecologic Cancer in Women with Lynch Syndrome Sarah E. Ferguson, MD FRCSC Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto June 11, 2013 Objective 1. To review the
Endometrial Cancer Treatment
Endometrial Cancer Treatment January 2006 By Shelly Smits, RHIT, CCS, CTR mary by Ian Thompson, MD Data Source: Cancer registry information on uterine cancer diagnosed 1/1/2000 to 12/31/2004. Reason for
Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?
ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM What is a hysterectomy? Hysterectomy Hysterectomy is
Advances in Surgical Oncology
3-4 December 2015 Advances in Surgical Oncology 3 rd International Conference of the Medical University of Lublin 10 th anniversary of first Intraoperative Radiotherapy in Lublin 1 Scientific Chairman
ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016
ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016 BUDAPEST (HU) ESSO Advanced Course on Oncoplastic Breast Surgery Course directors Tibor Kovacs, Guy s and St. Thomas NHS Foundation Trust,
Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda
Stomach (Gastric) Cancer Prof. M K Mahajan ACDT & RC Bathinda Gastric Cancer Role of Radiation Layers of the Stomach Mucosa Submucosa Muscularis Serosa Stomach and Regional Lymph Nodes Stomach and Regional
Guidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
ductal carcinoma in situ (DCIS)
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding
Treatment Guide Gynecologic Cancer
Treatment Guide Gynecologic Cancer Cleveland Clinic experts tailor treatment to their patients needs, taking into account the type of cancer, the degree to which the cancer has spread, the age of the individual
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
ESSO Course on Peritoneal Surface Malignancy
ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology 08-09 October 2015 MANCHESTER (UK) ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James
Breast Cancer Treatment Guidelines
Breast Cancer Treatment Guidelines DCIS Stage 0 TisN0M0 Tamoxifen for 5 years for patients with ER positive tumors treated with: -Breast conservative therapy (lumpectomy) and radiation therapy -Excision
Outcome of Early Cervical Carcinoma Treated by Wertheim Hysterectomy with Selective Postoperative Radiotherapy
ORIGINAL ARTICLES 613 Outcome of Early Cervical Carcinoma Treated by Wertheim Hysterectomy with Selective Postoperative Radiotherapy S K Tay,*FAMS, MD, FRCOG, L K Tan,**MBBS, M Med (O & G), MRCOG Abstract
Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
Invasive Cervical Cancer. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Invasive Cervical Cancer Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Etiology Human Papilloma Virus (HPV): Detected in 99.7% of cervical cancers Cancer
Radical Trachelectomy: A Fertility-Sparing Option for Early Invasive Cervical Cancer
REVIEWS IMAJ VOL 14 may 2012 Radical Trachelectomy: A Fertility-Sparing Option for Early Invasive Cervical Cancer Javier Mejia-Gomez MD, Tomer Feigenber MD, Sagit Arbel-Alon MD, Liron Kogan MD and Abraham
The Adnexal Mass and Early Ovarian Cancer
The Adnexal Mass and Early Ovarian Cancer Fred Ueland, MD University of Kentucky Gynecologic Oncology Never give in. Never give in. Never, never, never, never- in nothing great or small, large or petty-
Latest developments in management. Gianfilippo Bertelli Consultant Medical Oncologist Swansea
Latest developments in management Gianfilippo Bertelli Consultant Medical Oncologist Swansea Optimizing management of ovarian cancer in South Wales Diagnosis and referral pathways: Role of GPs, gynaecologists,
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka Neoadiuvant and adiuvant therapy for advanced gastric cancer Franco Roviello, IT Neoadjuvant and adjuvant therapy for advanced
Adjuvant Therapy for Breast Cancer: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
Fertility Preservation in Women with Cancer. Objectives. Patient #1 10/24/2011. The audience will understand: How cancer therapy affects fertility.
Fertility Preservation in Women with Cancer Leslie R. DeMars Dartmouth-Hitchcock Medical Center Objectives The audience will understand: How cancer therapy affects fertility. Who should be considered for
Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer
Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Dan Vogl Lay Abstract Early stage non-small cell lung cancer can be cured
SAMO FoROMe Post-ESMO 2013 Breast Cancer
SAMO FoROMe Post-ESMO 2013 Breast Cancer Dr. med. Manuela Rabaglio Klinik und Poliklinik für Medizinische Onkologie Breast Cancer Track 300 Abstracts 142 Poster 11 Proffered paper 4 late breaking news
Laparoscopic hysterectomy with or without pelvic. lymphadenectomy or sampling in a high-risk series of
Laparoscopic hysterectomy with or without pelvic lymphadenectomy or sampling in a high-risk series of patients with endometrial cancer Susan F Willis Thomas EJ Ind * Desmond Barton Department of Gynaecological
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy